Asia-Pacific Pen Needles Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Asia-Pacific Pen Needles Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Pharmaceutical
  • Upcoming Report
  • Oct 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC PEN NEEDLES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE ASIA-PACIFIC PEN NEEDLES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 SALES DATA VOLUME

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 ASIA-PACIFIC PEN NEEDLES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 INSTALLED BASE DATA

15 VALUE CHAIN ANALYSIS

16 HEALTHCARE ECONOMY

16.1 HEALTHCARE EXPENDITURE

16.2 CAPITAL EXPENDITURE

16.3 CAPEX TRENDS

16.4 CAPEX ALLOCATION

16.5 FUNDING SOURCES

16.6 INDUSTRY BENCHMARKS

16.7 GDP RATION IN OVERALL GDP

16.8 HEALTHCARE SYSTEM STRUCTURE

16.9 GOVERNMENT POLICIES

16.1 ECONOMIC DEVELOPMENT

17 ASIA-PACIFIC PEN NEEDLES MARKET, BY PRODUCT TYPE

17.1 OVERVIEW

17.2 STANDARD PEN NEEDLES

17.2.1 BY DELIVERY SYSTEMS

17.2.1.1. SINGLE DOSE DELIVERY SYSTEMS

17.2.1.2. MULTI-DOSE DELIVERY SYSTEM

17.2.2 BY TYPE

17.2.2.1. PRE FILLED NEEDLES

17.2.2.2. CONVENTIONAL NEEDLES

17.3 SAFETY PEN NEEDLES

17.3.1 BY DELIVERY SYSTEMS

17.3.1.1. SINGLE DOSE DELIVERY SYSTEMS

17.3.1.2. MULTI-DOSE DELIVERY SYSTEM

17.3.2 BY TYPE

17.3.2.1. PRE FILLED NEEDLES

17.3.2.2. CONVENTIONAL NEEDLES

18 ASIA-PACIFIC PEN NEEDLES MARKET, BY PRODUCT LENGTH

18.1 OVERVIEW

18.2 4MM

18.3 5MM

18.4 6MM

18.5 8MM

18.6 10MM

18.7 12MM

18.8 OTHERS

19 ASIA-PACIFIC PEN NEEDLES MARKET, BY THICKNESS

19.1 OVERVIEW

19.2 27G NEEDLE

19.3 29G NEEDLE

19.4 31G NEEDLE

19.5 32G NEEDLE

19.6 OTHERS

20 ASIA-PACIFIC PEN NEEDLES MARKET, BY USABILITY

20.1 OVERVIEW

20.2 REUSABLE

20.3 DISPOSABLE

21 ASIA-PACIFIC PEN NEEDLES MARKET, BY ROUTE OF ADMINISTRATION

21.1 OVERVIEW

21.2 INTRAMUSCULAR

21.3 SUBCUTANEOUS

21.4 HYPODERMIC

21.5 OTHERS

22 ASIA-PACIFIC PEN NEEDLES MARKET, BY APPLICATION

22.1 OVERVIEW

22.2 DIABETES

22.2.1 INSULIN THERAPY

22.2.2 GLUCAGON-LIKE PEPTIDE-1 THERAPY

22.3 GROWTH HORMONE DEFICIENCY

22.4 OTHERS

23 ASIA-PACIFIC PEN NEEDLES MARKET, BY END USER

23.1 OVERVIEW

23.2 HOSPITALS

23.2.1 PUBLIC

23.2.2 PRIVATE

23.3 SPECIALTY CLINICS

23.4 HOME HEALTHCARE

23.5 OTHERS

24 ASIA-PACIFIC PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL

24.1 OVERVIEW

24.2 DIRECT TENDER

24.3 RETAIL SALES

24.3.1 HOSPITAL PHARMACY

24.3.2 ONLINE PHARMACY

24.3.3 MEDICINE STORES

24.4 OTHERS

25 ASIA-PACIFIC PEN NEEDLES MARKET, COMPANY LANDSCAPE

25.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

25.2 MERGERS & ACQUISITIONS

25.3 NEW PRODUCT DEVELOPMENT & APPROVALS

25.4 EXPANSIONS

25.5 REGULATORY CHANGES

25.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

26 ASIA-PACIFIC PEN NEEDLES MARKET, BY GEOGRAPHY

ASIA-PACIFIC PEN NEEDLES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

26.1 ASIA-PACIFIC

26.1.1 JAPAN

26.1.2 CHINA

26.1.3 SOUTH KOREA

26.1.4 INDIA

26.1.5 AUSTRALIA

26.1.6 SINGAPORE

26.1.7 THAILAND

26.1.8 MALAYSIA

26.1.9 INDONESIA

26.1.10 PHILIPPINES

26.1.11 REST OF ASIA-PACIFIC

26.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

27 ASIA-PACIFIC PEN NEEDLES MARKET, SWOT AND DBMR ANALYSIS

28 ASIA-PACIFIC PEN NEEDLES MARKET, COMPANY PROFILE

28.1 NOVO NORDISK A/S

28.1.1 COMPANY OVERVIEW

28.1.2 REVENUE ANALYSIS

28.1.3 GEOGRAPHIC PRESENCE

28.1.4 PRODUCT PORTFOLIO

28.1.5 RECENT DEVELOPMENTS

28.2 BD

28.2.1 COMPANY OVERVIEW

28.2.2 REVENUE ANALYSIS

28.2.3 GEOGRAPHIC PRESENCE

28.2.4 PRODUCT PORTFOLIO

28.2.5 RECENT DEVELOPMENTS

28.3 A. MENARINI DIAGNOSTICS SRL

28.3.1 COMPANY OVERVIEW

28.3.2 REVENUE ANALYSIS

28.3.3 GEOGRAPHIC PRESENCE

28.3.4 PRODUCT PORTFOLIO

28.3.5 RECENT DEVELOPMENTS

28.4 B. BRAUN MELSUNGEN AG

28.4.1 COMPANY OVERVIEW

28.4.2 REVENUE ANALYSIS

28.4.3 GEOGRAPHIC PRESENCE

28.4.4 PRODUCT PORTFOLIO

28.4.5 RECENT DEVELOPMENTS

28.5 HTL-STREFA

28.5.1 COMPANY OVERVIEW

28.5.2 REVENUE ANALYSIS

28.5.3 GEOGRAPHIC PRESENCE

28.5.4 PRODUCT PORTFOLIO

28.5.5 RECENT DEVELOPMENTS

28.6 NIPRO EUROPE GROUP COMPANIES

28.6.1 COMPANY OVERVIEW

28.6.2 REVENUE ANALYSIS

28.6.3 GEOGRAPHIC PRESENCE

28.6.4 PRODUCT PORTFOLIO

28.6.5 RECENT DEVELOPMENTS

28.7 YPSOMED AG

28.7.1 COMPANY OVERVIEW

28.7.2 REVENUE ANALYSIS

28.7.3 GEOGRAPHIC PRESENCE

28.7.4 PRODUCT PORTFOLIO

28.7.5 RECENT DEVELOPMENTS

28.8 TERUMO CORPORATION

28.8.1 COMPANY OVERVIEW

28.8.2 REVENUE ANALYSIS

28.8.3 GEOGRAPHIC PRESENCE

28.8.4 PRODUCT PORTFOLIO

28.8.5 RECENT DEVELOPMENTS

28.9 OWEN MUMFORD LTD

28.9.1 COMPANY OVERVIEW

28.9.2 REVENUE ANALYSIS

28.9.3 GEOGRAPHIC PRESENCE

28.9.4 PRODUCT PORTFOLIO

28.9.5 RECENT DEVELOPMENTS

28.1 ULTIMED, INC.

28.10.1 COMPANY OVERVIEW

28.10.2 REVENUE ANALYSIS

28.10.3 GEOGRAPHIC PRESENCE

28.10.4 PRODUCT PORTFOLIO

28.10.5 RECENT DEVELOPMENTS

28.11 NARANG MEDICAL LIMITED

28.11.1 COMPANY OVERVIEW

28.11.2 REVENUE ANALYSIS

28.11.3 GEOGRAPHIC PRESENCE

28.11.4 PRODUCT PORTFOLIO

28.11.5 RECENT DEVELOPMENTS

28.12 TRIVIDIA HEALTH, INC.

28.12.1 COMPANY OVERVIEW

28.12.2 REVENUE ANALYSIS

28.12.3 GEOGRAPHIC PRESENCE

28.12.4 PRODUCT PORTFOLIO

28.12.5 RECENT DEVELOPMENTS

28.13 SIMPLE DIAGNOSTICS

28.13.1 COMPANY OVERVIEW

28.13.2 REVENUE ANALYSIS

28.13.3 GEOGRAPHIC PRESENCE

28.13.4 PRODUCT PORTFOLIO

28.13.5 RECENT DEVELOPMENTS

28.14 MEDEXEL CO., LTD.

28.14.1 COMPANY OVERVIEW

28.14.2 REVENUE ANALYSIS

28.14.3 GEOGRAPHIC PRESENCE

28.14.4 PRODUCT PORTFOLIO

28.14.5 RECENT DEVELOPMENTS

28.15 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD.

28.15.1 COMPANY OVERVIEW

28.15.2 REVENUE ANALYSIS

28.15.3 GEOGRAPHIC PRESENCE

28.15.4 PRODUCT PORTFOLIO

28.15.5 RECENT DEVELOPMENTS

28.16 FEEL TECH BIO

28.16.1 COMPANY OVERVIEW

28.16.2 REVENUE ANALYSIS

28.16.3 GEOGRAPHIC PRESENCE

28.16.4 PRODUCT PORTFOLIO

28.16.5 RECENT DEVELOPMENTS

28.17 ARKRAY, INC.

28.17.1 COMPANY OVERVIEW

28.17.2 REVENUE ANALYSIS

28.17.3 GEOGRAPHIC PRESENCE

28.17.4 PRODUCT PORTFOLIO

28.17.5 RECENT DEVELOPMENTS

28.18 SHANGHAI BEIPU MEDICAL CO., LTD.

28.18.1 COMPANY OVERVIEW

28.18.2 REVENUE ANALYSIS

28.18.3 GEOGRAPHIC PRESENCE

28.18.4 PRODUCT PORTFOLIO

28.18.5 RECENT DEVELOPMENTS

28.19 BIOACTIVA DIAGNOSTICA GMBH

28.19.1 COMPANY OVERVIEW

28.19.2 REVENUE ANALYSIS

28.19.3 GEOGRAPHIC PRESENCE

28.19.4 PRODUCT PORTFOLIO

28.19.5 RECENT DEVELOPMENTS

28.2 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD

28.20.1 COMPANY OVERVIEW

28.20.2 REVENUE ANALYSIS

28.20.3 GEOGRAPHIC PRESENCE

28.20.4 PRODUCT PORTFOLIO

28.20.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

29 RELATED REPORTS

30 CONCLUSION

31 QUESTIONNAIRE

32 ABOUT DATA BRIDGE MARKET RESEARCH